Abstract:Long-acting parenteral drug products are a popular choice for therapeutic areas requiring long term treatment. These products range from dispersed systems such as drug suspensions and polymeric microspheres to in situ forming polymeric implants. The lack of reliable drug release testing methods for these drug products not only impedes the development of new drug products but also affects generic drug development. Current release methods suffer from a range of problems such as high variability, poor reproducibility, poor discriminatory ability, lack of depot-like structure formation (that could mimic the in vivo situation). Moreover, shorter duration (less than a week) of release renders them unsuitable for in vitro-in vivo correlations (IVIVCs). To overcome these issues, novel adapters were developed for both USP-type-II & IV apparatus. These adapters were validated and assessed using the long-acting injectable (LAI) suspension drug product Depo Provera 150® as well as its Q1/Q2 equivalents. For USP-type-IV apparatus, two open adapter designs (conical and ellipsoidal shaped cavity with volume capacities of 50 µl and 1 ml, respectively) were developed. A closed conical adapter design with a volume capacity of 0.05 ml was developed for USP apparatus type-II. All three novel adapter designs effectively retained the suspensions, achieved release durations of 3-6 weeks with good reproducibility, minimal variability (RSD≤5%) and had good discriminatory ability. Based on this, the adapter-based dissolution methods were deemed suitable for IVIVC development of long-acting injectables. A successful Level A IVIVC was developed for Depo SubQ Provera 104® and its Q1Q2 equivalents using USP apparatus type IV with a conical adapter design. The closed adapter design for apparatus type-II was also investigated for suitability with risperidone in situ forming implants. The adapter was able to securely retain and maintain the shape of the in situ forming implants and resulted in release profiles of up to one month with good discriminatory ability and low standard error (RSD≤5%). These novel adapters hold promise of wide use for in vitro release testing of different long-acting parenteral drug products.

In Vitro Release Study of the Polymeric Drug Nanoparticles: Development and Validation of a Novel Method

In Vitro Dissolution Testing Strategies for Nanoparticulate Drug Delivery Systems: Recent Developments and Challenges

Surfactant Mediated Accelerated and Discriminatory In Vitro Drug Release Method for PLGA Nanoparticles of Poorly Water-Soluble Drug

Accelerated In-Vitro Release Testing Methods for Extended-Release Parenteral Dosage Forms

In Vitro Release Characterization of Tetracycline Hydrochloride from PLGA/Tetracycline Hydrochloride Electrospun Nanofiber Mats

Assessment of In Vitro Release Testing Methods for Colloidal Drug Carriers: The Lack of Standardized Protocols

In vitro dissolution considerations associated with nano drug delivery systems.

Study of the drug release kinetics in nanoscale micelle to micelle system

Optimization (Central Composite Design) and Validation of HPLC Method for Investigation of Emtricitabine Loaded Poly(lactic-co-glycolic acid) Nanoparticles: In Vitro Drug Release and In Vivo Pharmacokinetic Studies

Nanoparticles vs. nanofibers: a comparison of two drug delivery systems on assessing drug release performance in vitro

Accelerated in vitro release testing using USP apparatus 2 to predict rat in vivo performance of single agent and combination long-acting injectable suspension products

Novel dissolution methods for drug release testing of Long-Acting injectables

Designing a novel in vitro drug-release-testing method for liposomes prepared by pH-gradient method

A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl

A study on the preparation and in vitro release models of doxorubicin-nanoparticles

Development and Optimization of an in Vitro Release Assay for Evaluation of Liposomal Irinotecan Formulation

Microfluidisation trends in the development of nanodelivery systems: characterisation and release study of resveratrol‐loaded nanostructured lipid carrier prepared with high‐pressure microfluidisation

A Novel Accelerated in Vitro Release Method to Evaluate the Release of Thymopentin from PLGA Microspheres.

Preparation and Release Rate in Vitro of Puerarin Enteric Nanoparticles

Comparative study on the release behaviors of irinotecan loaded liposomes with two active loading methods

A bio-predictive release assay for liposomal prednisolone phosphate